Non-Aspergillus Hyaline Molds: A Host-Based Perspective of Emerging Pathogenic Fungi Causing Sinopulmonary Diseases
暂无分享,去创建一个
[1] B. Moriyama,et al. Osteoarticular Mycoses , 2022, Clinical microbiology reviews.
[2] D. Kontoyiannis,et al. Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions , 2022, Frontiers in Immunology.
[3] B. Patel,et al. Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu GM-CSF) as Adjuvant Therapy for Invasive Fungal Diseases , 2022, Open forum infectious diseases.
[4] D. Seidel,et al. Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope® registry , 2022, The Journal of antimicrobial chemotherapy.
[5] S. Ormanns,et al. Nivolumab induces long-term remission in a patient with fusariosis. , 2022, European journal of cancer.
[6] S. Ranque,et al. Species Identification and In Vitro Antifungal Susceptibility of Paecilomyces/Purpureocillium Species Isolated from Clinical Respiratory Samples: A Multicenter Study , 2022, Journal of fungi.
[7] R. Elhasid,et al. Invasive Fusariosis in Pediatric Hematology/Oncology and Stem Cell Transplant Patients: A Report from the Israeli Society of Pediatric Hematology-Oncology , 2022, Journal of fungi.
[8] OUP accepted manuscript , 2022, Clinical Infectious Diseases.
[9] M. Ghannoum,et al. GM-CSF: Orchestrating the Pulmonary Response to Infection , 2022, Frontiers in Pharmacology.
[10] N. Wiederhold. Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance , 2021, Clinical chemistry.
[11] D. Kontoyiannis,et al. How different is invasive fusariosis in pediatric patients than in adults? A systematic review , 2021, Current opinion in infectious diseases.
[12] A. Fuentefria,et al. Diversity of Fusarium species causing invasive and disseminated infections. , 2021, Journal de mycologie medicale.
[13] H. Badali,et al. In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes , 2021, Mycoses.
[14] S. Lockhart,et al. Molecular Techniques for Genus and Species Determination of Fungi From Fresh and Paraffin-Embedded Formalin-Fixed Tissue in the Revised EORTC/MSGERC Definitions of Invasive Fungal Infection. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] A. Barać,et al. Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literature , 2021, The Journal of antimicrobial chemotherapy.
[16] P. Woo,et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. , 2021, The Lancet. Infectious diseases.
[17] Paige M. K. Larkin,et al. Recognition of Diagnostic Gaps for Laboratory Diagnosis of Fungal Diseases: Expert Opinion from the Fungal Diagnostics Laboratories Consortium (FDLC) , 2021, Journal of clinical microbiology.
[18] M. Hoenigl,et al. Scedosporium and Lomentospora Infections: Contemporary Microbiological Tools for the Diagnosis of Invasive Disease , 2021, Journal of fungi.
[19] E. Pérez-Nadales,et al. Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000–2015 , 2021, Emerging infectious diseases.
[20] L. Moradi,et al. Invasive Rasamsonia argillacea infection in chronic granulomatous disease: Report of a new case and literature review. , 2020, Journal de mycologie medicale.
[21] D. Kontoyiannis,et al. Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections , 2020, Journal of fungi.
[22] L. Pagano,et al. Do high MICs predict the outcome in invasive fusariosis? , 2020, The Journal of antimicrobial chemotherapy.
[23] D. Seidel,et al. Characterization and outcome of invasive infections due to Paecilomyces variotii: analysis of patients from the FungiScope® registry and literature reports , 2020, The Journal of antimicrobial chemotherapy.
[24] Victor Pereira Rochetti,et al. Peptidorhamnomannans From Scedosporium and Lomentospora Species Display Microbicidal Activity Against Bacteria Commonly Present in Cystic Fibrosis Patients , 2020, Frontiers in Cellular and Infection Microbiology.
[25] F. Dromer,et al. Scedosporiosis/lomentosporiosis observational study (SOS): Clinical significance of Scedosporium species identification. , 2020, Medical mycology.
[26] B. Posteraro,et al. Update on MALDI-TOF MS Identification of Filamentous Fungi. , 2020, Journal of clinical microbiology.
[27] J. Guarro,et al. Sarocladium and Acremonium infections: New faces of an old opportunistic fungus , 2020, Mycoses.
[28] J. Buer,et al. In vitro activity of olorofim (F901318) against fungi of the genus, Scedosporium and Rasamsonia as well as against Lomentospora prolificans, Exophiala dermatitidis and azole-resistant Aspergillus fumigatus. , 2020, International journal of antimicrobial agents.
[29] M. Arendrup,et al. In Vitro Activity of Manogepix (APX001A) and Comparators against Contemporary Molds: MEC Comparison and Preliminary Experience with Colorimetric MIC Determination , 2020, Antimicrobial Agents and Chemotherapy.
[30] J. Frisvad,et al. Classification of Aspergillus, Penicillium, Talaromyces and related genera (Eurotiales): An overview of families, genera, subgenera, sections, series and species , 2020, Studies in mycology.
[31] M. Christner,et al. Clinical characteristics and outcomes of invasive Lomentospora prolificans infections: Analysis of patients in the FungiScope® registry , 2020, Mycoses.
[32] T. Walsh,et al. Non-Aspergillus Hyaline Molds: Emerging Causes of Sino-Pulmonary Fungal Infections and Other Invasive Mycoses , 2020, Seminars in Respiratory and Critical Care Medicine.
[33] M. Christner,et al. Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[34] 구자홍,et al. Aspergillosis , 2020, Red Book Atlas of Pediatric Infectious Diseases.
[35] P. Soler-Palacín,et al. Invasive Scedosporium spp. and Lomentospora prolificans Infections in Pediatric Patients: Analysis of 55 Cases from FungiScope® and the Literature. , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[36] Yiyou Gu,et al. Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis , 2019, Antimicrobial Agents and Chemotherapy.
[37] J. Perfect,et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] D. Seidel,et al. Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature , 2019, Mycoses.
[39] C. Hennequin,et al. In Vitro Susceptibility of Fusarium to Isavuconazole , 2019, Antimicrobial Agents and Chemotherapy.
[40] D. Kontoyiannis,et al. Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients , 2019, Antimicrobial Agents and Chemotherapy.
[41] M. Castanheira,et al. In Vitro Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017 , 2019, Antimicrobial Agents and Chemotherapy.
[42] F. Marty,et al. Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis? , 2019, Mycoses.
[43] J. Guarro,et al. Current knowledge on the etiology and epidemiology of Scopulariopsis infections. , 2019, Medical mycology.
[44] T. Walsh,et al. The expanding use of matrix-assisted laser desorption/ionization-time of flight mass spectroscopy in the diagnosis of patients with mycotic diseases , 2019, Expert review of molecular diagnostics.
[45] D. Pakstis,et al. Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope® , 2019, Critical reviews in microbiology.
[46] F. Dalle,et al. First case of proven invasive pulmonary infection due to Trichoderma longibrachiatum in a neutropenic patient with acute leukemia. , 2018, Journal de mycologie medicale.
[47] J. Guarro,et al. Lack of correlation of ECV and outcome in an in vivo murine model of systemic fusariosis. , 2018, Diagnostic microbiology and infectious disease.
[48] D. Capone,et al. Invasive mould disease in haematologic patients: comparison between fusariosis and aspergillosis. , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[49] H. Matsuoka,et al. Invasive Scopulariopsis alboflavescens infection in patient with acute myeloid leukemia , 2018, International Journal of Hematology.
[50] Davise H. Larone,et al. Larone’s Medically Important Fungi , 2018 .
[51] T. Walsh,et al. Recent Advances in the Treatment of Scedosporiosis and Fusariosis , 2018, Journal of fungi.
[52] E. Cober,et al. Fatal Fusarium infection manifesting as osteomyelitis following previous treatment with amphotericin B in a multi‐visceral transplant: Case report and review of Fusarium infections in solid organ transplantation , 2018, Transplant infectious disease : an official journal of the Transplantation Society.
[53] M. Arendrup,et al. EUCAST Determination of Olorofim (F901318) Susceptibility of Mold Species, Method Validation, and MICs , 2018, Antimicrobial Agents and Chemotherapy.
[54] S. Ranque,et al. Scedosporium and Lomentospora: an updated overview of underrated opportunists. , 2018, Medical mycology.
[55] F. Cobo,et al. Infections caused by Scedosporium/Lomentospora species: Clinical and microbiological findings in 21 cases , 2017, Medical mycology.
[56] E. Stindel,et al. Miltefosine-based regimen as salvage therapy in Lomentospora prolificans bone and joint infection. , 2017, Medecine et maladies infectieuses.
[57] S. Ranque,et al. Current antifungal treatment of fusariosis. , 2017, International journal of antimicrobial agents.
[58] J. Cano-Lira,et al. Ecology of Scedosporium Species: Present Knowledge and Future Research , 2018, Mycopathologia.
[59] J. Jarvis,et al. Modulating host immune responses to fight invasive fungal infections. , 2017, Current opinion in microbiology.
[60] R. Guillemain,et al. Clinical outcome of cystic fibrosis patients colonized by Scedosporium species following lung transplantation: A single‐center 15‐year experience , 2017, Transplant infectious disease : an official journal of the Transplantation Society.
[61] D. Seidel,et al. FungiScope™—Global Emerging Fungal Infection Registry , 2017, Mycoses.
[62] J. Wingard,et al. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[63] L. Blyn,et al. Fatal disseminated Rasamsonia infection in cystic fibrosis post-lung transplantation. , 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[64] S. de Botton,et al. Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patient , 2017, Infection.
[65] T. Walsh,et al. Scedosporiosis in a Combined Kidney and Liver Transplant Recipient: A Case Report of Possible Transmission from a Near-Drowning Donor , 2016, Case reports in transplantation.
[66] B. Buchan,et al. Treatment of Paecilomyces variotii pneumonia with posaconazole: case report and literature review , 2016, Mycoses.
[67] S. Suerbaum,et al. Fungal epidemiology and diversity in cystic fibrosis patients over a 5-year period in a national reference center. , 2016, Medical mycology.
[68] A. Rodríguez-Tovar,et al. Disseminated penicilliosis due to Penicillium chrysogenum in a pediatric patient with Henoch-Schönlein syndrome. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[69] J. Buer,et al. In Vitro Activity of Isavuconazole against Rasamsonia Species , 2016, Antimicrobial Agents and Chemotherapy.
[70] T. Walsh,et al. PCR methodology and applications for the detection of human fungal pathogens , 2016, Expert review of molecular diagnostics.
[71] J. Meis,et al. Global molecular epidemiology and genetic diversity of Fusarium, a significant emerging group of human opportunists from 1958 to 2015 , 2016, Emerging microbes & infections.
[72] M. Nucci,et al. Fusariosis. , 2020, Seminars in respiratory and critical care medicine.
[73] M. Ghannoum,et al. International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method , 2015, Antimicrobial Agents and Chemotherapy.
[74] W. G. Nichols,et al. Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection. , 2015, Blood.
[75] Sameer S. Kadri,et al. Role of granulocyte transfusions in invasive fusariosis: systematic review and single‐center experience , 2015, Transfusion.
[76] T. Walsh,et al. Importance of Fungal Histopathology in Immunocompromised Pediatric Patients: It's Not Just "Aspergillus" Anymore. , 2015, American journal of clinical pathology.
[77] N. Lima,et al. Molecular Biology of Food and Water Borne Mycotoxigenic and Mycotic Fungi , 2015 .
[78] Z. Wan,et al. In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species , 2015, Antimicrobial Agents and Chemotherapy.
[79] M. Battegay,et al. Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections. , 2015, The Journal of infectious diseases.
[80] A. Colombo,et al. Risk factors for invasive fusariosis in patients with acute myeloid leukemia and in hematopoietic cell transplant recipients. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[81] L. Fu,et al. An outbreak of invasive fusariosis in a children's cancer hospital. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[82] A. D. Diepeningen,et al. Spectrum of Fusarium infections in tropical dermatology evidenced by multilocus sequencing typing diagnostics , 2015, Mycoses.
[83] P. Reix,et al. Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[84] D. Horn,et al. Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance® registry , 2014, Mycoses.
[85] Z. Gu,et al. Quantitative multiplexed detection of common pulmonary fungal pathogens by labeled primer polymerase chain reaction. , 2014, Archives of pathology & laboratory medicine.
[86] M. Boccadoro,et al. Trichoderma species fungemia after high‐dose chemotherapy and autologous stem cell transplantation: a case report , 2014, Transplant Infectious Disease.
[87] A. Rosengart,et al. Mold infections of the central nervous system. , 2014, The New England journal of medicine.
[88] B. Alexander,et al. Complexities associated with the molecular and proteomic identification of Paecilomyces species in the clinical mycology laboratory. , 2014, Medical mycology.
[89] E. Anaissie,et al. Improvement in the outcome of invasive fusariosis in the last decade. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[90] M. Caira,et al. European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe , 2014, European Journal of Clinical Microbiology & Infectious Diseases.
[91] J. Guarro,et al. Phylogeny of the Clinically Relevant Species of the Emerging Fungus Trichoderma and Their Antifungal Susceptibilities , 2014, Journal of Clinical Microbiology.
[92] J. Guarro,et al. In vitro antifungal susceptibility of clinical isolates of Arthrographis kalrae, a poorly known opportunistic fungus , 2014, Mycoses.
[93] L. Pagano,et al. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[94] A. Velegraki,et al. Cluster of Fusarium verticillioides bloodstream infections among immunocompetent patients in an internal medicine department after reconstruction works in Larissa, Central Greece. , 2014, The Journal of hospital infection.
[95] M. Netea,et al. Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series , 2014, BMC Infectious Diseases.
[96] A. Colombo,et al. Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing , 2014, PloS one.
[97] T. Sorrell,et al. In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens. , 2013, The Journal of antimicrobial chemotherapy.
[98] Russell E. Lewis,et al. Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20‐year autopsy study , 2013, Mycoses.
[99] A. McLachlan,et al. Terbinafine in Combination with Other Antifungal Agents for Treatment of Resistant or Refractory Mycoses: Investigating Optimal Dosing Regimens Using a Physiologically Based Pharmacokinetic Model , 2013, Antimicrobial Agents and Chemotherapy.
[100] J. Guarro,et al. Scopulariopsis, a Poorly Known Opportunistic Fungus: Spectrum of Species in Clinical Samples and In Vitro Responses to Antifungal Drugs , 2013, Journal of Clinical Microbiology.
[101] M. Bougnoux,et al. Rasamsonia argillacea species complex: taxonomy, pathogenesis and clinical relevance. , 2013, Future microbiology.
[102] E. Roilides,et al. Non‐Aspergillus fungal infections in chronic granulomatous disease , 2013, Mycoses.
[103] L. Goldani,et al. Paecilomyces variotii as an Emergent Pathogenic Agent of Pneumonia , 2013, Case reports in infectious diseases.
[104] A. Velegraki,et al. An unusual cluster of Acremonium kiliense fungaemias in a haematopoietic cell transplantation unit. , 2013, Diagnostic microbiology and infectious disease.
[105] D. Ecker,et al. PCR Followed by Electrospray Ionization Mass Spectrometry for Broad-Range Identification of Fungal Pathogens , 2013, Journal of Clinical Microbiology.
[106] Steven M Holland,et al. Invasive fungal infections in patients with chronic granulomatous disease. , 2013, Advances in experimental medicine and biology.
[107] D. Siraj,et al. Use of Voriconazole for the Treatment of Paecilomyces lilacinus Cutaneous Infections: Case Presentation and Review of Published Literature , 2013, Mycopathologia.
[108] S. Holland,et al. Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management , 2012, Current opinion in infectious diseases.
[109] J. Frisvad,et al. Taxonomy and Antifungal Susceptibility of Clinically Important Rasamsonia Species , 2012, Journal of Clinical Microbiology.
[110] Z. Gu,et al. Evaluation of multiplexed PCR and liquid-phase array for identification of respiratory fungal pathogens. , 2012, Medical mycology.
[111] P. Iwen,et al. Invasive Scopulariopsis brevicaulis infection in an immunocompromised patient and review of prior cases caused by Scopulariopsis and Microascus species. , 2012, Medical mycology.
[112] P. Hartemann,et al. Fusarium species recovered from the water distribution system of a French university hospital. , 2012, International journal of hygiene and environmental health.
[113] J. Meis,et al. Species-Specific Antifungal Susceptibility Patterns of Scedosporium and Pseudallescheria Species , 2012, Antimicrobial Agents and Chemotherapy.
[114] A. Fischer,et al. Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[115] Ronald N. Jones,et al. Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods , 2011, Antimicrobial Agents and Chemotherapy.
[116] J. Frisvad,et al. Rasamsonia, a new genus comprising thermotolerant and thermophilic Talaromyces and Geosmithia species , 2011, Antonie van Leeuwenhoek.
[117] I. Grigoriev,et al. Trichoderma: the genomics of opportunistic success , 2011, Nature Reviews Microbiology.
[118] G. Papanicolaou,et al. Invasive Non-Aspergillus Mold Infections in Transplant Recipients, United States, 2001–2006 , 2011, Emerging infectious diseases.
[119] T. Horii,et al. In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds , 2011, Antimicrobial Agents and Chemotherapy.
[120] J. Houbraken,et al. Purpureocillium, a new genus for the medically important Paecilomyces lilacinus. , 2011, FEMS microbiology letters.
[121] N. Young,et al. Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[122] S. Holland,et al. Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[123] W. Meyer,et al. Development and Validation of a Multiplex PCR for Detection of Scedosporium spp. in Respiratory Tract Specimens from Patients with Cystic Fibrosis , 2011, Journal of Clinical Microbiology.
[124] O. Lortholary,et al. Emergence of Disseminated Infections Due to Geosmithia argillacea in Patients with Chronic Granulomatous Disease Receiving Long-Term Azole Antifungal Prophylaxis , 2011, Journal of Clinical Microbiology.
[125] E. Mylonakis,et al. Fusarium Infection in Lung Transplant Patients: Report of 6 Cases and Review of the Literature , 2011, Medicine.
[126] J. Latgé,et al. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. , 2010, Blood.
[127] J. Guarro,et al. Spectrum of Clinically Relevant Acremonium Species in the United States , 2010, Journal of Clinical Microbiology.
[128] M. Montagna,et al. Chronic airway colonization by Scedosporium apiospermum with a fatal outcome in a patient with cystic fibrosis. , 2010, Medical mycology.
[129] D. Geiser,et al. Internet-Accessible DNA Sequence Database for Identifying Fusaria from Human and Animal Infections , 2010, Journal of Clinical Microbiology.
[130] D. Kontoyiannis,et al. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. , 2010, The Journal of infection.
[131] J. Bouchara,et al. Acremonium strictum Fungaemia in a Paediatric Immunocompromised Patient: Diagnosis and Treatment Difficulties , 2010, Mycopathologia.
[132] N. Young,et al. Granulocyte transfusions in severe aplastic anemia: an eleven-year experience , 2009, Haematologica.
[133] O. Lee,et al. Detection of Occult Scedosporium Species in Respiratory Tract Specimens from Patients with Cystic Fibrosis by Use of Selective Media , 2009, Journal of Clinical Microbiology.
[134] P. Bordigoni,et al. Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient: case report and review of the literature , 2009 .
[135] T. Sorrell,et al. Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[136] T. Mohammed,et al. Pseudallescheria boydii (Scedosporium species) in 3 Lung Transplant Recipients: Computed Tomography Findings and Literature Review , 2009, Journal of computer assisted tomography.
[137] E. Anaissie,et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[138] T. Walsh,et al. Host immune response against Scedosporium species. , 2009, Medical mycology.
[139] L. Zhao,et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. , 2008, The New England journal of medicine.
[140] R. D. Stulting,et al. Fusarium keratitis and contact lens wear: facts and speculations. , 2008, Medical mycology.
[141] J. Guarro,et al. Central nervous system infections by members of the Pseudallescheria boydii species complex in healthy and immunocompromised hosts: epidemiology, clinical characteristics and outcome , 2008, Mycoses.
[142] E. Mellado,et al. Susceptibility Testing and Molecular Classification of Paecilomyces spp , 2008, Antimicrobial Agents and Chemotherapy.
[143] J. Bruzzi,et al. Imaging of pulmonary fusariosis in patients with hematologic malignancies. , 2008, AJR. American journal of roentgenology.
[144] A. Baruchel,et al. Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[145] T. V. Van Schooneveld,et al. Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature , 2008, Transplant infectious disease : an official journal of the Transplantation Society.
[146] T. Walsh,et al. Amphotericin B formulations variably enhance antifungal activity of human neutrophils and monocytes against Fusarium solani: comparison with Aspergillus fumigatus. , 2008, The Journal of antimicrobial chemotherapy.
[147] D. Ellis,et al. Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 Patients , 2008, Antimicrobial Agents and Chemotherapy.
[148] Thomas J. Walsh,et al. Infections Caused by Scedosporium spp , 2008, Clinical Microbiology Reviews.
[149] B. Esmaeli,et al. Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases , 2008, European Journal of Clinical Microbiology & Infectious Diseases.
[150] L. Griškevičius,et al. Nonfatal Trichoderma citrinoviride pneumonia in an acute myeloid leukemia patient , 2008, Annals of Hematology.
[151] S. Burdach,et al. Lethal double infection with Acremonium strictum and Aspergillus fumigatus during induction chemotherapy in a child with ALL , 2007, Pediatric blood & cancer.
[152] T. Walsh,et al. Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay. , 2007, Diagnostic microbiology and infectious disease.
[153] T. Walsh,et al. Fungal infections in primary immunodeficiencies , 2007, European Journal of Pediatrics.
[154] D. Paterson,et al. Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: Successful combination therapy with voriconazole and terbinafine , 2007, Scandinavian journal of infectious diseases.
[155] N. Okhravi,et al. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[156] D. Kleiner,et al. Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. , 2005, American journal of clinical pathology.
[157] Russell E. Lewis,et al. Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[158] R. Yamazaki,et al. Systemic infection due to Acremonium after allogeneic peripheral blood stem cell transplantation. , 2006, Internal medicine.
[159] K. Wannemuehler,et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. , 2006, JAMA.
[160] T. Wong,et al. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. , 2006, JAMA.
[161] M. J. Buitrago,et al. In Vitro Activities of 10 Combinations of Antifungal Agents against the Multiresistant Pathogen Scopulariopsis brevicaulis , 2006, Antimicrobial Agents and Chemotherapy.
[162] J. Graybill,et al. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[163] M. J. Buitrago,et al. Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi , 2006, Antimicrobial Agents and Chemotherapy.
[164] S. Holland,et al. Effect of Amphotericin B and Micafungin Combination on Survival, Histopathology, and Fungal Burden in Experimental Aspergillosis in the p47phox−/− Mouse Model of Chronic Granulomatous Disease , 2006, Antimicrobial Agents and Chemotherapy.
[165] S. Burdette,et al. Intestinal invasion and disseminated disease associated with Penicillium chrysogenum , 2005, Annals of Clinical Microbiology and Antimicrobials.
[166] C. Burgaleta,et al. Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: report of one case and review of the literature. , 2005, Diagnostic microbiology and infectious disease.
[167] E. Bash,et al. Fatal necrotizing esophagitis due toPenicillium chrysogenum in a patient with acquired immunodeficiency syndrome , 1992, European Journal of Clinical Microbiology and Infectious Diseases.
[168] T. Walsh,et al. Control, immunoregulation, and expression of innate pulmonary host defenses against Aspergillus fumigatus. , 2005, Medical mycology.
[169] Nina Singh,et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[170] R. Herbrecht,et al. Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[171] J. Robinson,et al. Genetic Diversity of Human Pathogenic Members of the Fusarium oxysporum Complex Inferred from Multilocus DNA Sequence Data and Amplified Fragment Length Polymorphism Analyses: Evidence for the Recent Dispersion of a Geographically Widespread Clonal Lineage and Nosocomial Origin , 2004, Journal of Clinical Microbiology.
[172] T. Walsh,et al. Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children. , 2004, The Pediatric infectious disease journal.
[173] E. Anaissie,et al. Fusarium infection in hematopoietic stem cell transplant recipients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[174] J. Peter,et al. Efficacy, Safety, and Plasma Pharmacokinetics of Escalating Dosages of Intravenously Administered Ravuconazole Lysine Phosphoester for Treatment of Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits , 2004, Antimicrobial Agents and Chemotherapy.
[175] D. Kontoyiannis,et al. The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer , 2004, Cancer.
[176] T J Walsh,et al. Infections due to emerging and uncommon medically important fungal pathogens. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[177] J. Perfect,et al. Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients. , 2004, The Journal of infection.
[178] C. Viscoli,et al. Successful treatment of Acremonium fungemia with voriconazole , 2003, Mycoses.
[179] D. Kontoyiannis,et al. Glucocorticoids and invasive fungal infections , 2003, The Lancet.
[180] M. Pfaller,et al. Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi , 2003, Journal of Clinical Microbiology.
[181] E. Anaissie,et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection , 2003, Cancer.
[182] J. Perfect,et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[183] D. Leehey,et al. Paecilomyces peritonitis: case report and review of the literature. , 2003, Clinical nephrology.
[184] John H Rex,et al. Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies. , 2003, Blood.
[185] Paul E. Verweij,et al. In Vitro Drug Interaction Modeling of Combinations of Azoles with Terbinafine against Clinical Scedosporium prolificans Isolates , 2003, Antimicrobial Agents and Chemotherapy.
[186] L. Lachaud,et al. Invasive infections due to Trichoderma species: report of 2 cases, findings of in vitro susceptibility testing, and review of the literature. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[187] R. Herbrecht,et al. Acremonium strictum Pulmonary Infection in a Leukemic Patient Successfully Treated with Posaconazole After Failure of Amphotericin B , 2002, European Journal of Clinical Microbiology and Infectious Diseases.
[188] E. Anaissie,et al. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[189] D. Denning,et al. Invasive infection due to penicillium species other than P. marneffei. , 2002, The Journal of infection.
[190] M. Gompels,et al. Scedosporium apiospermum in chronic granulomatous disease treated with an HLA matched bone marrow transplant , 2002, Journal of clinical pathology.
[191] J. Fung,et al. Pseudallescheria boydii (Anamorph Scedosporium apiospermum) Infection in Solid Organ Transplant Recipients in a Tertiary Medical Center and Review of the Literature , 2002, Medicine.
[192] M. Albitar,et al. Epidemiology, Molecular Mycology, and Environmental Sources of Fusarium Infection in Patients with Cancer , 2002, Infection Control & Hospital Epidemiology.
[193] T. Walsh,et al. Antifungal Triazoles and Polymorphonuclear Leukocytes Synergize To Cause Increased Hyphal Damage to Scedosporium prolificans and Scedosporium apiospermum , 2002, Antimicrobial Agents and Chemotherapy.
[194] T. Walsh,et al. Synergy, Pharmacodynamics, and Time-Sequenced Ultrastructural Changes of the Interaction between Nikkomycin Z and the Echinocandin FK463 against Aspergillus fumigatus , 2001, Antimicrobial Agents and Chemotherapy.
[195] S. Chanock,et al. Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[196] Alice N. Neely,et al. Survival of Some Medically Important Fungi on Hospital Fabrics and Plastics , 2001, Journal of Clinical Microbiology.
[197] J. Rodríguez-Tudela,et al. Airborne outbreak of nosocomial Scedosporium prolificans infection , 2001, The Lancet.
[198] C. Payá,et al. Fusarium infection after solid-organ transplantation. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[199] M. Jacobson,et al. Invasive Fungal Sinusitis and Meningitis Due toArthrographis kalrae in a Patient with AIDS , 2001, Journal of Clinical Microbiology.
[200] J. Guarro,et al. Mixed Infection Caused by Two Species ofFusarium in a Human Immunodeficiency Virus-Positive Patient , 2000, Journal of Clinical Microbiology.
[201] J. Bouchara,et al. Clinical Significance of Scedosporium apiospermum in Patients with Cystic Fibrosis , 2000, European Journal of Clinical Microbiology and Infectious Diseases.
[202] J. Montoya,et al. Invasive fungal sinusitis due to Scedosporium apiospermum in a patient with AIDS. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[203] W. Liles,et al. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. , 1999, The Journal of infectious diseases.
[204] C. Thio,et al. Paecilomyces lilacinus fungemia in an adult bone marrow transplant recipient. , 1999, Medical mycology.
[205] A. Fischer,et al. Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[206] P. H. Itina,et al. Cutaneous manifestations of Paecilomyces lilacinus infection induced by a contaminated skin lotion in patients who are severely immunosuppressed , 1998 .
[207] J. Rich,et al. Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases. , 1998, Chest.
[208] Johnson M Liu,et al. Invasive Infection with Fusarium chlamydosporum in a Patient with Aplastic Anemia , 1998, Journal of Clinical Microbiology.
[209] J. Perfect,et al. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. , 1998, American journal of clinical pathology.
[210] J. Guarro,et al. Acremonium species: new emerging fungal opportunists--in vitro antifungal susceptibilities and review. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[211] E. Anaissie,et al. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. , 1997, Blood.
[212] N. Giri,et al. Invasive aspergillosis in human immunodeficiency virus-infected children. , 1997, The Pediatric infectious disease journal.
[213] S. Rossmann,et al. Trichoderma longibrachiatum infection in a pediatric patient with aplastic anemia , 1997, Journal of clinical microbiology.
[214] P. Itin,et al. Outbreak of Invasive Mycoses Caused by Paecilomyces lilacinus from a Contaminated Skin Lotion , 1996, Annals of Internal Medicine.
[215] J. Perfect,et al. Fatal, disseminated Acremonium strictum infection in a neutropenic host , 1996, Journal of clinical microbiology.
[216] J. Martínez-Suárez,et al. Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients , 1995, Journal of clinical microbiology.
[217] E. Roilides,et al. Acremonium fungemia in two immunocompromised children. , 1995, The Pediatric infectious disease journal.
[218] E. Anaissie,et al. Taxonomy, biology, and clinical aspects of Fusarium species , 1994, Clinical Microbiology Reviews.
[219] D. Venzon,et al. Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-gamma. , 1994, The Journal of infectious diseases.
[220] B. Kjos,et al. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[221] N. M. Brown,et al. Acremonium infection in a neutropenic patient. , 1992, The Journal of infection.
[222] J. Levine,et al. Scopulariopsis Peritonitis in a Patient Undergoing Continuous Ambulatory Peritoneal Dialysis , 1992, Peritoneal Dialysis International.
[223] G. Phillips,et al. Invasive hyalohyphomycosis caused by Scopulariopsis brevicaulis in a patient undergoing allogeneic bone marrow transplant. , 1989, Diagnostic microbiology and infectious disease.
[224] J. Karp,et al. Diagnosis and successful treatment of fusariosis in the compromised host. , 1988, The Journal of infectious diseases.
[225] J. Neglia,et al. Invasive Scopulariopsis in the immunocompromised host. , 1987, The American journal of medicine.
[226] R. Foos,et al. Fungal endophthalmitis following intraocular lens implantation. A surgical epidemic. , 1980, Archives of ophthalmology.